AI
ABBVIE INC
ABBV· Health Care· BiotechnologyS&P 500
Close · 15/09/2026
263.04
1D
+0.49%52-week range
190.75 – 267.47
Volume
51,19,300.00
Price history
ABBV
14/08/2026 to 15/09/2026
O 260.00 H 264.81 L 257.80
1W+5.73%
1M+5.44%
3M+18.71%
6M+18.78%
1Y+20.47%
3Y+76.51%
5Y+141.25%
MAX+123.09%
Fundamentals
as of 15/09/2026- Market cap
- $464.82B
- Shares out
- 1.77B
- P/E (trailing)
- 73.66
- P/E (forward)
- 15.79
- EPS (trailing)
- 3.57
- Dividend yield
- 2.60%
- Beta
- 0.28
- Profit margin
- 9.80%
- P/B
- -76.55
SEC financial statements
58 quarterly and 15 annual periods through 30/06/2026.
Details
- Ticker
- ABBV
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 15/09/2026.
Tracked by Congress
25 filers · 2 on watchlist · 42 buys · 40 sells · 1 option · ?: 11 · D: 41 · R: 30
- 27/03/2026Alan ArmstrongBuyAbbVie Inc. Common Stock$15,001–$50,000
- 05/05/2026Josh GottheimerWSellAbbVie Inc. Common Stock$1,001–$15,000
- 18/12/2025Julie JohnsonSellAbbVie Inc. Common Stock$1,001–$15,000
- 08/12/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 28/04/2025Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000
- 24/01/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000
- 13/11/2025Julie JohnsonSell+AbbVie Inc. Common Stock$1,001–$15,000